"Designing Growth Strategies is in our DNA"

Diabetes Drugs Market Size, Share & Industry Analysis, By Drug Class (Insulin, GLP-1 Receptor Agonists, DPP-4 Inhibitors, SGLT2 Inhibitors, and Others), By Diabetes Type (Type 1, and Type 2), By Route of Administration (Oral, Subcutaneous, and Intravenous), By Distribution Channel (Online pharmacies, Hospital Pharmacies, and Retail Pharmacies), and Regional Forecast, 2024-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI100570

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Diabetes, by Type, for Key Countries / Region, 2023
    2. Cost Burden, Diabetes, Key Countries, 2023
    3. Pipeline Analysis, by Key Players
    4. New Product Launches, by Key Players
    5. Key Industry Developments Such as Mergers, Acquisitions, and Collaborations
    6. Impact of COVID-19 on Global Diabetes Drug Market
  5. Global Diabetes Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Insulin
      2. DPP-4 Inhibitors
      3. GLP-1 Receptor Agonists
      4. SGLT2 Inhibitors
      5. Others
    2. Market Analysis, Insights and Forecast – By Diabetes Type
      1. Type-1
      2. Type-2
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Subcutaneous
      3. Intravenous
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Diabetes Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Insulin
      2. DPP-4 Inhibitors
      3. GLP-1 Receptor Agonists
      4. SGLT2 Inhibitors
      5. Others
    2. Market Analysis, Insights and Forecast – By Diabetes Type
      1. Type-1
      2. Type-2
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Subcutaneous
      3. Intravenous
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Diabetes Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Insulin
      2. DPP-4 Inhibitors
      3. GLP-1 Receptor Agonists
      4. SGLT2 Inhibitors
      5. Others
    2. Market Analysis, Insights and Forecast – By Diabetes Type
      1. Type-1
      2. Type-2
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Subcutaneous
      3. Intravenous
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Diabetes Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Insulin
      2. DPP-4 Inhibitors
      3. GLP-1 Receptor Agonists
      4. SGLT2 Inhibitors
      5. Others
    2. Market Analysis, Insights and Forecast – By Diabetes Type
      1. Type-1
      2. Type-2
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Subcutaneous
      3. Intravenous
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Diabetes Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Insulin
      2. DPP-4 Inhibitors
      3. GLP-1 Receptor Agonists
      4. SGLT2 Inhibitors
      5. Others
    2. Market Analysis, Insights and Forecast – By Diabetes Type
      1. Type-1
      2. Type-2
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Subcutaneous
      3. Intravenous
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Diabetes Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Insulin
      2. DPP-4 Inhibitors
      3. GLP-1 Receptor Agonists
      4. SGLT2 Inhibitors
      5. Others
    2. Market Analysis, Insights and Forecast – By Diabetes Type
      1. Type-1
      2. Type-2
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Subcutaneous
      3. Intravenous
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa 
  11. Competitive Analysis
    1. Global Market Share Analysis (2023)
    2. Company Profiles
      1. Sanofi
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      2. Novo Nordisk A/S
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      3. Eli Lily & Company
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      4. AstraZeneca
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      5. Takeda Pharmaceutical Company Limited
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      6. Novartis AG
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      7. Janssen Pharmaceuticals, Inc. (Johnson & Johnson Services Inc.)
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      8. Bayer AG
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
Read Less

Figure 1: Global Diabetes Drugs Market Revenue Breakdown (USD billion, %) by Region, 2023 & 2032

Figure 2: Global Diabetes Drugs Market Value Share (%), by Drug Class, 2023 & 2032

Figure 3: Global Diabetes Drugs Market Value Share (%), by Diabetes Type, 2023 & 2032

Figure 4: Global Diabetes Drugs Market Value Share (%), by Route of Administration, 2023 & 2032

Figure 5: Global Diabetes Drugs Market Value Share (%), by Distribution Channel, 2023 & 2032

Figure 6: Global Diabetes Drugs Market Value (USD billion), by Region, 2023 & 2032

Figure 7: North America Diabetes Drugs Market Value (USD billion), by Drug Class, 2023 & 2032

Figure 8: North America Diabetes Drugs Market Value Share (%), by Drug Class, 2023

Figure 9: North America Diabetes Drugs Market Value (USD billion), by Diabetes Type, 2023 & 2032

Figure 10: North America Diabetes Drugs Market Value Share (%), by Diabetes Type, 2023

Figure 11: North America Diabetes Drugs Market Value (USD billion), by Route of Administration, 2023 & 2032

Figure 12: North America Diabetes Drugs Market Value Share (%), by Route of Administration, 2023

Figure 13: North America Diabetes Drugs Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 14: North America Diabetes Drugs Market Value Share (%), by Distribution Channel, 2023

Figure 15: North America Diabetes Drugs Market Value (USD billion), By Country, 2023 & 2032

Figure 16: North America Diabetes Drugs Market Value Share (%), By Country, 2023

Figure 17: Europe Diabetes Drugs Market Value (USD billion), by Drug Class, 2023 & 2032

Figure 18: Europe Diabetes Drugs Market Value Share (%), by Drug Class, 2023

Figure 19: Europe Diabetes Drugs Market Value (USD billion), by Diabetes Type, 2023 & 2032

Figure 20: Europe Diabetes Drugs Market Value Share (%), by Diabetes Type, 2023

Figure 21: Europe Diabetes Drugs Market Value (USD billion), by Route of Administration, 2023 & 2032

Figure 22: Europe Diabetes Drugs Market Value Share (%), by Route of Administration, 2023

Figure 23: Europe Diabetes Drugs Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 24: Europe Diabetes Drugs Market Value Share (%), by Distribution Channel, 2023

Figure 25: Europe Diabetes Drugs Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 26: Europe Diabetes Drugs Market Value Share (%), By Country/ Sub-region, 2023

Figure 27: Asia Pacific Diabetes Drugs Market Value (USD billion), by Drug Class, 2023 & 2032

Figure 28: Asia Pacific Diabetes Drugs Market Value Share (%), by Drug Class, 2023

Figure 29: Asia Pacific Diabetes Drugs Market Value (USD billion), by Diabetes Type, 2023 & 2032

Figure 30: Asia Pacific Diabetes Drugs Market Value Share (%), by Diabetes Type, 2023

Figure 31: Asia Pacific Diabetes Drugs Market Value (USD billion), by Route of Administration, 2023 & 2032

Figure 32: Asia Pacific Diabetes Drugs Market Value Share (%), by Route of Administration, 2023

Figure 33: Asia Pacific Diabetes Drugs Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 34: Asia Pacific Diabetes Drugs Market Value Share (%), by Distribution Channel, 2023

Figure 35: Asia Pacific Diabetes Drugs Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 36: Asia Pacific Diabetes Drugs Market Value Share (%), By Country/ Sub-region, 2023

Figure 37: Latin America Diabetes Drugs Market Value (USD billion), by Drug Class, 2023 & 2032

Figure 38: Latin America Diabetes Drugs Market Value Share (%), by Drug Class, 2023

Figure 39: Latin America Diabetes Drugs Market Value (USD billion), by Diabetes Type, 2023 & 2032

Figure 40: Latin America Diabetes Drugs Market Value Share (%), by Diabetes Type, 2023

Figure 41: Latin America Diabetes Drugs Market Value (USD billion), by Route of Administration, 2023 & 2032

Figure 42: Latin America Diabetes Drugs Market Value Share (%), by Route of Administration, 2023

Figure 43: Latin America Diabetes Drugs Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 44: Latin America Diabetes Drugs Market Value Share (%), by Distribution Channel, 2023

Figure 45: Latin America Diabetes Drugs Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 46: Latin America Diabetes Drugs Market Value Share (%), By Country/ Sub-region, 2023

Figure 47: Middle East & Africa Diabetes Drugs Market Value (USD billion), by Drug Class, 2023 & 2032

Figure 48: Middle East & Africa Diabetes Drugs Market Value Share (%), by Drug Class, 2023

Figure 49: Middle East & Africa Diabetes Drugs Market Value (USD billion), by Diabetes Type, 2023 & 2032

Figure 50: Middle East & Africa Diabetes Drugs Market Value Share (%), by Diabetes Type, 2023

Figure 51: Middle East & Africa Diabetes Drugs Market Value (USD billion), by Route of Administration, 2023 & 2032

Figure 52: Middle East & Africa Diabetes Drugs Market Value Share (%), by Route of Administration, 2023

Figure 53: Middle East & Africa Diabetes Drugs Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 54: Middle East & Africa Diabetes Drugs Market Value Share (%), by Distribution Channel, 2023

Figure 55: Middle East & Africa Diabetes Drugs Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 56: Middle East & Africa Diabetes Drugs Market Value Share (%), By Country/ Sub-region, 2023

Figure 57: Global Diabetes Drugs Market Share (%), By Company, 2023

Table 1: Global Diabetes Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019–2032

Table 2: Global Diabetes Drugs Market Revenue (USD billion) Forecast, by Diabetes Type, 2019–2032

Table 3: Global Diabetes Drugs Market Revenue (USD billion) Forecast, by Route of Administration, 2019–2032

Table 4: Global Diabetes Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 5: Global Diabetes Drugs Market Revenue (USD billion) Forecast, by Region, 2019-2032

Table 6: North America Diabetes Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 7: North America Diabetes Drugs Market Revenue (USD billion) Forecast, by Diabetes Type, 2019-2032

Table 8: North America Diabetes Drugs Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 9: North America Diabetes Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 10: North America Diabetes Drugs Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 11: Europe Diabetes Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 12: Europe Diabetes Drugs Market Revenue (USD billion) Forecast, by Diabetes Type, 2019-2032

Table 13: Europe Diabetes Drugs Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 14: Europe Diabetes Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 15: Europe Diabetes Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 16: Asia Pacific Diabetes Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 17: Asia Pacific Diabetes Drugs Market Revenue (USD billion) Forecast, by Diabetes Type, 2019-2032

Table 18: Asia Pacific Diabetes Drugs Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 19: Asia Pacific Diabetes Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 20: Asia Pacific Diabetes Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 21: Latin America Diabetes Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 22: Latin America Diabetes Drugs Market Revenue (USD billion) Forecast, by Diabetes Type, 2019-2032

Table 23: Latin America Diabetes Drugs Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 24: Latin America Diabetes Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 25: Latin America Diabetes Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 26: Middle East & Africa Diabetes Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 27: Middle East & Africa Diabetes Drugs Market Revenue (USD billion) Forecast, by Diabetes Type, 2019-2032

Table 28: Middle East & Africa Diabetes Drugs Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 29: Middle East & Africa Diabetes Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 30: Middle East & Africa Diabetes Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Diabetes Drugs Market Size, Share and Global Industry Trend Forecast till 2032
  • 2019-2032
  • 2023
  • 2019-2022
  • 126
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase